Skip to main content
Clinical Trials/NCT05790512
NCT05790512CompletedNot Applicable

Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection

Xijing Hospital of Digestive Diseases1 site in 1 country500 target enrollmentStarted: November 22, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
500
Locations
1
Primary Endpoint
Positive rate of oral Helicobacter pylori

Study Overview

Brief Summary

The aim of this study was to investigate the association between oral Helicobacter pylori infection and gastric Helicobacter pylori infection. Patients who were tested for gastric Helicobacter pylori were tested for oral Helicobacter pylori at the same time, and were divided into four groups according to the test results to compare the positive rate of oral Helicobacter pylori.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age between 18~70 ,both gender.
  • Initial diagnosis of stomach Helicobacter pylori infection or never had Helicobacter pylori infection.
  • Have not received dental care or systemic periodontal basic treatment in the past 1 year.

Exclusion Criteria

  • There is serious organ damage and complications (such as cirrhosis, uremia, etc.), severe or unstable cardiopulmonary or endocrine diseases.
  • Ongoing use of antiulcer medications (including PPIs taken within 2 weeks before Helicobacter pylori infection testing), antibiotics, or bismuth complexes (more than 3 times/week before screening).
  • Those with severe oral diseases and malignant tumors of the mouth.
  • Previously had upper gastrointestinal surgery.
  • Refusal to sign informed consent.

Outcomes

Primary Outcomes

Positive rate of oral Helicobacter pylori

Time Frame: 7 months

The oral Helicobacter pylori test is performed using the Helicobacter pylori test kit

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Xijing Hospital of Digestive Diseases
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yongquan Shi

Principal Investigator, Clinical Professor

Xijing Hospital of Digestive Diseases

Study Sites (1)

Loading locations...

Similar Trials